Healthcare provider profile · identity verified

Kyle S Leonard, MD

Family Practice · QUEENSBURY, NY · NPI 1871886978

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	133
Omeprazole	Omeprazole	236	64
Amlodipine Besylate	Amlodipine Besylate	215	66
Gabapentin	Gabapentin	181	41
Losartan Potassium	Losartan Potassium	176	52
Lisinopril	Lisinopril	172	50
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	165	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	158	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	155	20
Rosuvastatin Calcium	Rosuvastatin Calcium	138	43
Albuterol Sulfate Hfa	Albuterol Sulfate	130	31
Mounjaro	Tirzepatide	115	25
Oxycodone Hcl	Oxycodone Hcl	109	13
Metoprolol Succinate	Metoprolol Succinate	101	44
Famotidine	Famotidine	91	27
Metformin Hcl	Metformin Hcl	90	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	89	14
Simvastatin	Simvastatin	87	19
Alprazolam	Alprazolam	85	17
Duloxetine Hcl	Duloxetine Hcl	85	20
Tamsulosin Hcl	Tamsulosin Hcl	84	23
Jardiance	Empagliflozin	78	17
Trazodone Hcl	Trazodone Hcl	78	13
Metformin Hcl Er	Metformin Hcl	67	19
Prednisone	Prednisone	64	47
Potassium Chloride	Potassium Chloride	60	18
Fluticasone Propionate	Fluticasone Propionate	58	24
Nortriptyline Hcl	Nortriptyline Hcl	58	19
Tramadol Hcl	Tramadol Hcl	57	15
Hydrochlorothiazide	Hydrochlorothiazide	56	20
Ozempic	Semaglutide	55	suppressed
Furosemide	Furosemide	52	17
Venlafaxine Hcl Er	Venlafaxine Hcl	52	12
Celecoxib	Celecoxib	47	11
Pantoprazole Sodium	Pantoprazole Sodium	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	18
Eliquis	Apixaban	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	suppressed
Pregabalin	Pregabalin	41	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	11
Clonazepam	Clonazepam	40	suppressed
Mirtazapine	Mirtazapine	39	13
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Sertraline Hcl	Sertraline Hcl	36	12
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	32
Glipizide Er	Glipizide	33	suppressed
Allopurinol	Allopurinol	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Spironolactone	Spironolactone	31	11
Meloxicam	Meloxicam	30	17
Memantine Hcl	Memantine Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Dexlansoprazole Dr	Dexlansoprazole	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	17
Ibuprofen	Ibuprofen	29	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Trulicity	Dulaglutide	27	suppressed
Finasteride	Finasteride	26	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	12
Montelukast Sodium	Montelukast Sodium	26	suppressed
Carvedilol	Carvedilol	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Topiramate	Topiramate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Fentanyl	Fentanyl	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	19	suppressed
Atenolol	Atenolol	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	11
Buspirone Hcl	Buspirone Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Chlorzoxazone	Chlorzoxazone	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Alprazolam Er	Alprazolam	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Modafinil	Modafinil	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Temazepam	Temazepam	12	suppressed
Topiramate Er	Topiramate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Amoxicillin	Amoxicillin	11	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error